-
Hydrogen plays part in global warming: study
-
EU's Mercosur trade deal hits French, Italian roadblock
-
What next for Belarus after US deal on prisoners, sanctions?
-
Brazil Senate debates bill that could slash Bolsonaro jail term
-
Coe shares 'frustration' over marathon record despite Kenyan's doping ban
-
Stolen Bruce Lee statue 'returns' to Bosnia town
-
Veteran Suarez signs new Inter Miami contract
-
Warner Bros rejects Paramount bid, sticks with Netflix
-
Crude prices surge after Trump orders Venezuela oil blockade
-
Balkan nations offer lessons on handling cow virus sowing turmoil
-
French readers lap up Sarkozy's prison diaries
-
UK PM warns Abramovich 'clock is ticking' over Chelsea sale fund
-
Warner Bros. Discovery rejects Paramount bid
-
Winners of 2026 World Cup to pocket $50 million in prize money
-
World no. 1 Alcaraz ends 'incredible ride' with coach Ferrero
-
World number one Alcaraz announces 'difficult' split with coach Ferrero
-
Iran boxer sentenced to death at 'imminent' risk of execution: rights groups
-
Snicko operator admits error that led to Carey's Ashes reprieve
-
Finland PM apologises to Asian countries over MPs' mocking posts
-
Doctors in England go on strike for 14th time
-
Romania journalists back media outlet that sparked graft protests
-
Rob Reiner's son awaiting court appearance on murder charges
-
Ghana's Highlife finds its rhythm on UNESCO world stage
-
Stocks gain as traders bet on interest rate moves
-
France probes 'foreign interference' after malware found on ferry
-
Europe's Ariane 6 rocket puts EU navigation satellites in orbit
-
Bleak end to the year as German business morale drops
-
Hundreds queue at Louvre museum as strike vote delays opening
-
Bondi shooting shocks, angers Australia's Jewish community
-
Markets rise even as US jobs data fail to boost rate cut bets
-
Senegal talisman Mane overcame grief to become an African icon
-
Carey pays tribute to late father after home Ashes century
-
'Many lessons to be learned' from Winter Games preparations, says ski chief
-
Emotional Carey slams ton to give Australia upper hand in 3rd Ashes Test
-
Asian markets mixed as US jobs data fails to boost rate cut hopes
-
Carey slams ton as Australia seize upper hand in third Ashes Test
-
Bondi shooting shocks, angers Australia Jewish community
-
Myanmar junta seeks to prosecute hundreds for election 'disruption'
-
West Indies hope Christmas comes early in must-win New Zealand Test
-
Knicks beat Spurs in NBA Cup final to end 52-year trophy drought
-
Khawaja revels in late lifeline as Australia 194-5 in 3rd Ashes Test
-
Grief and fear as Sydney's Jewish community mourns 'Bondi rabbi'
-
Trump orders blockade of 'sanctioned' Venezuela oil tankers
-
Brazil Senate to debate bill to slash Bolsonaro jail term
-
New Zealand ex-top cop avoids jail time for child abuse, bestiality offences
-
Eurovision facing fractious 2026 as unity unravels
-
'Extremely exciting': the ice cores that could help save glaciers
-
Asian markets drift as US jobs data fails to boost rate cut hopes
-
What we know about Trump's $10 billion BBC lawsuit
-
Ukraine's lost generation caught in 'eternal lockdown'
| SCS | 0.12% | 16.14 | $ | |
| RBGPF | 0.5% | 82.01 | $ | |
| CMSC | -0.21% | 23.29 | $ | |
| BTI | 0.2% | 57.405 | $ | |
| GSK | 0.8% | 49.175 | $ | |
| BCE | -0.17% | 23.29 | $ | |
| RIO | 1.5% | 77.145 | $ | |
| BCC | -0.03% | 75.815 | $ | |
| NGG | 1.63% | 77.025 | $ | |
| RYCEF | 0.8% | 14.92 | $ | |
| RELX | 0.02% | 40.83 | $ | |
| CMSD | -0.52% | 23.26 | $ | |
| AZN | -0.46% | 90.93 | $ | |
| JRI | -0.67% | 13.42 | $ | |
| BP | 1.47% | 34.265 | $ | |
| VOD | 0.59% | 12.775 | $ |
Bayer says legal woes could force it to pull weedkiller
German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to limit simmering legal troubles.
"We're nearing a point where the litigation industry could force us to even stop selling this vital product," CEO Bill Anderson said at Bayer's annual general meeting.
The Leverkusen-based group has said that after rumbling on for years, it has the aim of "significantly containing litigation by the end of 2026".
"The status quo is not an option," said Anderson, while the stakes for the chemicals and pharmaceuticals producer were "really high".
Bayer has been dogged by lawsuits linked to Roundup since it acquired the US manufacturer Monsanto in a blockbuster deal in 2018.
Claimants have alleged that glyphosate, the active ingredient in Roundup, causes blood cancers but Bayer says scientific studies and regulatory approvals show that the weedkiller is safe.
Bayer has battled to draw a line under Roundup litigation, spending more than $10 billion (8.8 billion euros) to date to settle suits alleging that Bayer failed to disclose health risks.
Earlier this month, Bayer said it would launch another appeal to the US Supreme Court to rule on the Roundup case, its third such attempt.
After being twice rebuffed by the court, Bayer is hopeful of more success following rulings by federal appellate courts, which the German group said support its case.
The renewed request for the Supreme Court to intervene is the first since Anderson took the reins at the chemicals group in 2023.
But Anderson's late arrival has not insulated the American manager from the criticism of shareholders, who voiced their impatience at the meeting.
Bayer has asked investors to approve a capital increase through the issuance of new stock to cover potential legal costs related to Roundup.
Shareholders were being asked to "pay the price" for Roundup's issues, Deka Investment manager Ingo Speich said, describing the move as a "bitter pill to swallow".
"Why should everything be different this time and the wave of lawsuits stopped with more money?", Janne Werning of Union Investment said.
A.Moore--AT